Coral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.
01 1Coral Drugs Private Limited
02 1Symbiotec Pharmalab
03 1Beijing Mesochem Technology
04 1LGM Pharma
05 1Gonane Pharma
06 1Jai Radhe Sales
07 1Anuh Pharma LTD
08 1Atomgrid
09 1Bayer AG
10 1Berr Chemical Company Ltd
11 1Curia
12 1Envee Drugs
13 1Grefuel
14 1Hanways Chempharm
15 1Huvepharma Italia S.r.l
16 1Mahima Life Sciences
17 1Micro Orgo Chem
18 1NEWCHEM SPA
19 1Olon S.p.A
20 1Sneha Medicare Pvt Ltd
21 1Sterling Spa
22 1Symbiotica Specialty Ingredients
23 1Tianjin Tianyao Pharmaceuticals Co., Ltd.
24 1Unimax Group
25 1Vaishali Pharma Ltd
01 4China
02 1Germany
03 13India
04 4Italy
05 1Malaysia
06 2U.S.A
01 5Active
02 1Inactive
03 19Blank
01 25Blank
01 25Blank
01 25Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-12-20
Pay. Date : 2023-11-22
DMF Number : 38936
Submission : 2023-10-05
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-05
Pay. Date : 2021-11-02
DMF Number : 24691
Submission : 2011-03-02
Status : Active
Type : II
NDC Package Code : 22552-0027
Start Marketing Date : 2011-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-03-08
Pay. Date : 2023-03-06
DMF Number : 30313
Submission : 2016-03-02
Status : Active
Type : II
NDC Package Code : 64918-1111
Start Marketing Date : 2014-10-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-07-28
Pay. Date : 2021-05-26
DMF Number : 35535
Submission : 2021-04-26
Status : Active
Type : II
NDC Package Code : 57582-040
Start Marketing Date : 2021-06-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-07-11
Pay. Date : 2023-05-19
DMF Number : 38357
Submission : 2023-05-19
Status : Active
Type : II
NDC Package Code : 24002-0036
Start Marketing Date : 2021-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4922
Submission : 1983-03-17
Status : Inactive
Type : II
A Deflazacort manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deflazacort, including repackagers and relabelers. The FDA regulates Deflazacort manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deflazacort API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deflazacort manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deflazacort supplier is an individual or a company that provides Deflazacort active pharmaceutical ingredient (API) or Deflazacort finished formulations upon request. The Deflazacort suppliers may include Deflazacort API manufacturers, exporters, distributors and traders.
click here to find a list of Deflazacort suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 25 companies offering Deflazacort
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?